RareCyte, Inc. – Trademark Portfolio
Entity Type: 03
RareCyte, Inc. owns a portfolio of 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as A, LEO, ARTEMIS, CYTEHUB, and CYTEMAP. Of these, 18 are registered and 1 is pending. The portfolio spans 5 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 1 (Chemicals). Headquartered in Seattle, WA.
Suite 100
228 9th Avenue North
Seattle, WA 98109
Showing of trademarks Trademarks
Trademark Classifications
RareCyte, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does RareCyte, Inc. have?
RareCyte, Inc. has 42 U.S. trademarks filed with the USPTO. Of these, 18 registered, 1 pending, 19 abandoned, 4 cancelled.
What trademark classes does RareCyte, Inc. file in?
RareCyte, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are RareCyte, Inc.'s most well-known trademarks?
RareCyte, Inc.'s registered trademark portfolio includes well-known marks such as A, LEO, ARTEMIS, CYTEHUB, and CYTEMAP. These are among 18 currently registered trademarks in the portfolio.
What is RareCyte, Inc.'s trademark registration success rate?
RareCyte, Inc. has a 44% trademark registration rate, with 18 out of 41 resolved applications resulting in successful registration. Currently, 1 application is pending review.